Pharmaceutical Market Europe • October 2025 • 5
CONTENTS
October 2025
NEWS & COLUMNS
6-7 NEWS
GSK agrees on $12bn deal with Hengrui; BMS acquires Orbital Therapeutics in $1.5bn deal
8-10 NEWS
Pfizer agrees on US pricing and distribution deal; AstraZeneca announces agreement with US to reduce medicine costs
11 DERMATOLOGY NEWS
Pelage’ alopecia treatment moves forward to phase 3 trial; J&J’s Tremfya approved by FDA for children with plaque psoriasis
12 DARWIN'S MEDICINE
Creativity cages – thinking outside the box
13 RESILIENCE AND WELL-BEING
Resilience isn’t always about standing strong
14 LEGACY BRANDS
Why legacy brands remain critical
15 BUILDING RESILIENCE
Helping teams adapt and thrive
FEATURES
16-17 THE THREE NON-NEGOTIABLE PILLARS OF ALZHEIMER’S BLOOD TESTING
Projections estimate that an alarming 153 million people will be living with Alzheimer’s or related dementias by 2050 – why sensitivity, access and education will define scalable Alzheimer’s diagnostics
18-19 ADDRESSING THE CLINICAL TRIAL ACCESS GAP
Physician-driven, AI-supported: addressing the clinical trial access gap – to open up more clinical paths for patients, HCPs need simpler search tools, better access to information and integrated referral systems that fit into their clinical workflows
20-22 CLINICAL PATHWAY MANAGEMENT
Overcoming the barriers to global application of platelet measurement – why platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials
COMMUNIQUE
MARKETING & COMMS
24-25 INDIA’S GROWING ROLE IN PHARMA LOGISTICS
In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever.
28-30 NAVIGATING THE ‘PATIENT METRO’
Gathering and using patient insights is like having your ear to the rail track to hear what is coming down the line and do something about it. The key to unravelling its potential is to focus on the intersections where journeys are made or broken. When you decide to address a broken pathway, it is the patients that can indicate where to start first; they know what isn’t working
32-33 GenAI TOOLS – CREATING A NEW ERA OF SCIENTIFIC RESEARCH
An overwhelming majority (94%) of corporate R&D professionals believe that AI will accelerate knowledge discovery – looking at the new wave of GenAI-powered search tools now offering researchers an alternative method for accessing insights at speed
CAREERS & RECRUITMENT
36-38 APPOINTMENTS
Each month, we bring you the latest news on job changes in the pharma sector. This month, we are highlighting change at Sanofi, Merck, Genmab and Johnson & Johnson
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services